Innovation Driven by Purpose
Quantum Surgical is a purpose-driven company, aiming to transform cancer treatment with robotics and AI. Thanks to our team of creative and visionary experts, Quantum Surgical develops innovative solutions to ensure that as many patients as possible can benefit from a curative treatment.
Who we are
Our mission is threefold
Offering patients a minimally invasive and effective treatment for greater comfort.
At Quantum Surgical, we dream of a world where every patient can benefit from an effective treatment that improves their quality of life. Our expertise in medical robotics and artificial intelligence allows us to offer hope to patients who until now had no therapeutic options.
Helping physicians with complex tumor ablation procedures.
By exploring new approaches and relying on feedback from physicians and patients, Quantum Surgical develops increasingly refined solutions to meet their needs and offer ever less invasive tumor treatments.
Enabling hospitals to treat more patients:
As the WHO predicts a 77% increase in cancer cases by 2050, hospitals can now rely on technologies that work to improve their workflows and provide effective treatments to even more patients.
News & press releases
%20(1)-min.png)
Quantum Surgical in the media
Timeline
Awards
Galien USA Prize
In 2022, Quantum Surgical received the Galien USA Prize, which is the equivalent of the Nobel Prize in biopharmaceutical research.
French Tech 2030
Quantum Surgical joined the governmental French Tech 2030 program in 2023, which supports top emerging actors in disruptive innovation.
Award of the French National Institute of Industrial Property
The Awards of the French National Institute of Industrial Property annually honor innovative and promising companies that place industrial property at the core of their development strategy. Quantum Surgical has been awarded the prize in the Start-up category.
2023 JFR Innovation Award from the French Society of Radiology and Medical Imaging
Quantum Surgical has been awarded the 2023 JFR Innovation Prize in the ‘Interventional Imaging’ category for its Epione® robot. Presented by the French Society of Radiology and Medical Imaging, this award recognizes industry leaders who bring innovations to various areas of diagnostic and interventional medical imaging.
ISO 27001:2023
In December 2024, Quantum Surgical has obtained ISO 27001:2023 certification, which attests to the security and rigor of its data management system.
Our team
Executive Comitee
.jpg)
.jpg)
Board members
Bertin Nahum
Fernand Badano
Kevin Reilly
Robert Thompson
Joseph de Vivo
Quantum Surgical was founded by visionary leaders with over 30 years of expertise in robotic technology: Bertin Nahum (CEO), Fernand Badano (Managing director), Lucien Blondel (CTO) and Sophie Roca (Executive assistant). The team met while working at Medtech, the previous medical robotics company founded by Bertin Nahum and sold to Zimer Biomet in 2016. They have been working together for over 15 years.
Quantum Surgical is pioneering transformative solutions for early, curative cancer care through cutting-edge medical robotics and artificial intelligence.
At Quantum Surgical, we aim to revolutionize interventional oncology by integrating robotic-assisted technologies that have been clinically proven to have positive outcomes. We are committed to improving the quality of life for patients by offering innovative, minimally invasive solutions that enhance precision, safety, and clinical excellence. We measure our success by the positive impact we have on patient outcomes, and we are driven to inspire advancements in healthcare by focusing on what matters: providing superior, accessible, and life-changing care to those who need it most.
Our mission is threefold:
• For patients: Offering patients a minimally invasive and effective treatment for greater comfort. At Quantum Surgical, we dream of a world where every patient can benefit from an effective treatment that improves their quality of life. Our expertise in medical robotics and artificial intelligence allows us to offer hope to patients who until now had no therapeutic options.
• For physicians: Helping physicians with complex tumor ablation procedures. Exploring new approaches and relying on feedback from doctors and patients, Quantum Surgical develops increasingly refined solutions to meet their needs and offer ever less invasive tumor treatments.
• For hospitals: Enabling hospitals to treat more patients: As the WHO predicts a 77% increase in cancer cases by 2050, hospitals can now rely on technologies that work to improve their workflows and provide effective treatments to treat even more patients.